Rapid Virologic Suppression With Dolutegravir Plus Lamivudine Facilitates Early Switch to Long-Acting Cabotegravir Plus Rilpivirine for Treatment-Naive People With HIV-1: Month 11/12 Outcomes From the Phase 3b VOLITION Study. (academic.oup.com)

Authors: Cordova E … van Wyk J Journal: Open Forum Infectious Diseases Published: 2026-09-01 DOI: https://doi.org/10.1093/ofid/ofag383